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Abstract
Introduction: Patients with age-related degenerative changes in the cervical spine leading to
cervical spondylosis may be symptomatic or asymptomatic. Older patients with radicular pain
tend to have a better response to epidural steroid injections, but it is often difficult to predict
which patients will have a positive response to selective nerve root block (SNRB). We analyzed
whether the cervical neuroforaminal area measured on MRI predicts immediate therapeutic
responses to SNRB in patients who have cervical radiculopathy.
Methods: We retrospectively reviewed all patients who had cervical SNRBs treated at a single
tertiary referral center. We recorded patient demographics, the neuroforaminal area of the
symptomatic and contralateral sides, Visual Analog Scale (VAS) score pre- and post-injection,
history of previous cervical surgery, comorbidities, and history of tobacco use.
Results: Sixty-four patients with symptoms of cervical radiculopathy treated with
neuroforaminal nerve root injections had appropriate imaging and VAS scores recorded. The
average foraminal area of the symptomatic side before treatment was significantly smaller than
the contralateral asymptomatic neuroforamen (p<0.0001). Those patients with the smallest
neuroforamen had a positive response to SNRB. Diabetes and tobacco use did not influence
patient response to treatment.
Conclusions: Measurement of neuroforaminal areas on MRI may represent a useful preprocedural technique to predict which patients with symptoms of cervical radiculopathy
secondary to foraminal stenosis are likely to respond to selective nerve root injections. The
predictive ability appears to be limited to those patients with severe stenosis and was less useful
in those patients with moderate or mild stenosis.
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Introduction
Age-related degenerative changes in the cervical spine leading to cervical spondylosis are
commonly observed in both symptomatic and asymptomatic patients. Spondylotic changes can
lead to a broad range of overlapping symptoms, including axial neck pain, cervical radiculopathy,
cervical myelopathy, or myeloradiculopathy, although corresponding changes on magnetic
resonance imaging (MRI) do not always exist. Currently at our institution, some patients with
symptomatic spondylotic changes are initially treated with a diagnostic/therapeutic selective
nerve root block (SNRB). While many patients have a very good response to the injection, there
remains a large subset of patients that, despite correlating MRI and clinical findings, fail to have
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a positive response to the injection. The efficacy of lumbar SNRBs remains unconfirmed, with
mixed reports in the literature [1-2], and studies investigating the efficacy of cervical nerve root
injections and parameters that influence response to injection are scarce.
Previous work has suggested older patients with radicular pain tend to have a better response to
both transforaminal and interlaminar cervical epidural steroid injections [3-5], but it is often
difficult to predict which patients will have a positive response to SNRB. A surgeon's personal
experience and the characteristics of the patient’s spine on MRI (e.g., hard disc, soft disc,
osteophytes) also weigh significantly on who is referred for nerve root injection, and little
literature exists regarding the role of the neuroforaminal area in clinical response. We
hypothesized that patients with foraminal areas below a critical threshold in size would not have
a good response to injection because of limited anesthetic/steroid penetration. The purpose of
this study was to assess whether the cervical neuroforaminal area measured on MRI can be used
to predict immediate therapeutic responses to cervical SNRB in patients with symptoms of
cervical radiculopathy.

Materials And Methods
After receiving approval from the University of Utah Institutional Review Board (protocol
#53330) with a waiver of informed consent, we undertook a retrospective review of patients who
had undergone a cervical SNRB over a two-year period (January, 2009–December, 2010) treated
at our tertiary referral center. Inclusion/exclusion criteria included patients referred to our
department for surgical evaluation of symptoms of cervical radiculopathy (motor, sensory, or
pain), an MRI ≤ 6 months old available for direct review, no findings of cervical myelopathy, and
no history of previous cervical surgery. All patients had a clinical history of cervical
radiculopathy with MRI findings corresponding to physical examination findings. No patients
with cervical myelopathy or purely axial neck pain were included in the analysis. Only patients
receiving injections for a single level were included. We collected patient demographics, the
Visual Analog Scale (VAS) score pre- and post-injection, history of previous cervical surgery,
comorbidities, and history of tobacco use.
All SNRBs were done with fluoroscopic guidance using a biplane fluoroscopic unit. The patient
was placed in the supine position. The vertebral and facet joint margins were aligned under
fluoroscopy. The target was the superior articular process of the same number vertebra as the
nerve being injected. Approximately 1 mL of 2% lidocaine was used for local analgesia. The
needle was then deflected anteriorly into the neural foramen. Approximately 2 mL of
myelography-safe iodinated contrast agent was used for the needle tip confirmation in the nerve
root sleeve. The contrast pattern was identified as intraneural, perineural, and, most
importantly, not intra-arterial. The injectate used in these procedures was 1 mL of 10 mg/mL
dexamethasone and 1 mL of 1% lidocaine. We used nonparticulate steroids (dexamethasone) for
our neural foraminal injections because of the reported risk of embolic infarctions due to
inadvertent intra-arterial injection of particulate steroids [6-7]. A post-procedure VAS score was
obtained 30 minutes after the injection by the treating neurointerventionalist.
We measured the neuroforaminal area of the symptomatic side, using the asymptomatic
contralateral side as the internal control. Measurements of neuroforaminal areas were made by
both a spine neurosurgeon and a neuroradiologist blinded to patient VAS scores. Measurements
were performed on the MRI Digital Imaging and Communications in Medicine (DICOM) data set,
imported into the Osirix software (version 3.8.1 32-bit). The sagittal T2-weighted sequences were
selected and post-processed with the three-dimensional multi-projection reformat program.
Using the crosshairs, maximal neuroforaminal dimensions were evaluated at the level of interest
in the oblique sagittal plane by each observer independently. The region of interest tool was used
to calculate the maximum dimension of the neural foramen in the oblique sagittal plane (Figure
1).
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FIGURE 1: The region of interest tool was used to calculate the maximum dimension of the
neural foramen in the oblique sagittal plane.

Statistical analysis
Statistical analyses were performed using a Student t-test for paired ipsilateral and contralateral
foraminal area. Analyses involving continuous variables across four groups were performed using
ANCOVA, with diabetes and smoking status as covariates. The analyses were performed using
SPSS. All tests were two-sided, and a P-value <0.05 was used to indicate statistical significance.

Results
Sixty-four patients were identified for inclusion in this study. The average age of the subjects in
the cohort was 48.1 ± 8.9 years (range: 24–70 years). The distribution by sex was approximately
equal (Table 1). Twenty percent of patients were current or former smokers. A small minority of
patients were diabetic (6.3%), with the most common comorbidity being hypertension (15%). The
most commonly treated level was C5/6 (29 patients, 45.3%); 24 (37.5%) patients were treated at
C6/7, and the number of patients treated at other levels was much lower.

N = 64 (%)
Sex
Female
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Male

33 (51.6)

Number of patients treated at each spinal level (%)
C3-4

2 (3.1)

C4-5

4 (6.3)

C5-6

29 (45.3)

C6-7

24 (37.5)

C7-T1

5 (7.8)

Smoking status
Current

10 (15.6)

Former

3 (4.7)

Never

51 (79.7)

Diabetes
Yes

4 (6.3)

No

60 (93.8)

Comorbidities
Heart disease

2 (3.1)

Hypertension

10 (15.6)

Chronic obstructive pulmonary disease

1 (1.6)

TABLE 1: Characteristics of patients treated with cervical selective nerve root block

The measurements of the foraminal area between the two reviewers were averaged for the
purpose of our analysis. The range of deviation between the two reviewers for each subject was 0.227 to 0.182 cm 2, with an average deviation of 0.001 cm 2. The reviewers were not significantly
different in their measurements of foraminal area (p=0.829, paired t-test).
The average foraminal area of the side ipsilateral to injection (0.154 ± 0.118 cm 2) was
significantly smaller than the contralateral asymptomatic side, respectively (0.224 ± 0.113 cm2)
(P=0.0001). Mean pre-procedural VAS score for all patients was 5.48 ± 2.23 (range: 1–10) and
mean post-procedural VAS score (30 minutes after the procedure) was 1.91 ± 2.65 (range: 0–10).
The average improvement in VAS for all patients after injection was 3.58 ± 2.68 points. An
excellent response to SNRB was defined as complete resolution of arm pain, a good response was
defined as at least a 50% reduction in arm pain, and a fair or poor response was defined as a less
than 50% reduction in arm pain or no response to injection [8]. Forty-three of the 64 patients had
a good/excellent response to injection (67%). Ten patients (16%) had a fair response to injection,
nine patients (14%) had no response to injection, and two patients (3%) reported higher VAS
scores after injection.
Table 2 provides a summary of clinical outcomes based on the degree of foraminal stenosis. The
overall range of foraminal areas was 0.0145 to 0.5005 cm2.

Area range (cm2)

n

Mean VAS benefit

0.0145 – 0.1360

35

3.80 ± 2.52
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0.1370 – 0.2575

17

3.18 ± 2.60

0.2576 – 0.3790

8

2.25 ± 3.45

0.3800 – 0.5005

4

6 ± 0.81

0.140

TABLE 2: Mean change in VAS score by degree of stenosis as measured by foraminal area

The foraminal areas were arbitrarily divided into four equal ranges, with the majority of patients
falling into the group with the smallest neuroforaminal areas. In the groups with the most
stenosis, we observed a trend in VAS scores with those patients with the highest degree of
stenosis (i.e., the smallest foraminal area), having the greatest response to injection. Despite this
initial trend, Group 4, those patient's with minimal foraminal stenosis 0.379–0.5005 cm2 (n=4),
also reported a significant improvement in VAS score after injection. The level of benefit
between the four groups was not statistically significant (p=0.140). None of the patients had been
treated with oral methylprednisolone. Diabetes and smoking status were not statistically
significant predictors of patient response to injection.

Discussion
Our results suggest that patients with severe neuroforaminal narrowing benefit from cervical
SNRB. While our study involved only a small group of patients, our results did not support our
initial hypothesis. We had anticipated finding a subset of patients with very small foraminal
areas that would not respond SNRB. Our hypothesis was based on the idea that there would be a
critical stenosis or foraminal area that was too small to allow adequate steroid/anesthetic
penetration. In contrast, our results suggest that patients with very small neuroforaminal areas
are likely to have an immediate response to injection while patients with mild to moderate
stenosis are less predictable. Interestingly, we also observed four patients with minimal
foraminal stenosis that reported a dramatic improvement in VAS scores (6 ± 0.81) after SNRB. An
excellent response was consistently reported in all four patients. One hypothesis to explain the
outcome for these patients is that neural foraminal narrowing may be occurring in the dynamic
flexion/extension position, which is not assessed on the standard static supine MRI [9]. An
alternative explanation would be that these four patients had a more chemical radiculitis because
of a tear in the annulus and spread of inflammatory cytokines into the epidural space. This may
explain their symptoms of radiculopathy without an appreciable disc herniation [10-11] and may
explain why these patients experienced a favorable response despite minimal foraminal
narrowing.
Cervical SNRBs are often used as both a diagnostic and a therapeutic adjuvant in the
management of degenerative cervical spondylosis [12-13]. While there is still considerable
debate about whether local anesthetic alone or a combination of local anesthetic and
corticosteroids is more effective [14-19], SNRBs have been demonstrated to be a useful treatment
option in patients with both degenerative cervical and lumbar spondylosis. Multiple authors
have suggested that patients older than 50 years of age with radicular symptoms respond better
to cervical epidural steroid injections, yet often anecdotal experience weighs heavily on patient
selection [3-4, 20]. Although positive imaging findings suggestive of neuroforaminal compromise
provide some guidance in patient selection [21], MRI findings have not been reliably shown to be
predictive of a positive response to SNRB, and there is little or no literature on how cervical
foraminal area correlates with patient response to SNRB.
The use of interlaminar and transforaminal epidural steroid injections in the lumbar spine have
been well described in the literature [1-2]. Less literature is available regarding the efficacy of
injections in the cervical spine [12-13, 15], with only a few prospective randomized trials
reported to date [14, 22]. Bush, et al. [22] prospectively studied 68 patients with symptoms of
cervical radiculopathy treated with serial epidural or periradicular corticosteroid injections. At an
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average of 39 months follow-up, 76% (48 patients) had resolution of radicular symptoms without
any surgical intervention. More recently, Anderberg, et al. [14] prospectively reviewed a series of
40 patients with cervical radiculopathy that underwent SNRB with either a combination of
corticosteroids and local anesthetic or local anesthetic alone. A three-week follow-up time point
revealed no significant difference between the treatment groups. The authors suggest steroids
may not provide any additional benefit in patients undergoing SNRB for symptoms of cervical
radiculopathy.
MRI findings of cervical spondylosis are exceedingly common after the age of 50 years of age [2324], and while it is common to have MRI findings of spondylosis without corresponding clinical
symptoms, it is also common to encounter the opposite with minimal radiographic findings and
strong subjective clinical complaints. Interpreting the MRI findings and correlating these to
patient complaints can be challenging; however, Strobel, et al. [21] demonstrated that the most
important MRI finding predictive of response to transforaminal epidural steroid injection is
neuroforaminal involvement. They retrospectively reviewed the results of 93 patients treated
with transforaminal epidural steroid injections to determine whether MRI findings could predict
response to treatment. The authors assessed pre- and post-procedure VAS scores in patients
treated with a combination of local anesthetic and corticosteroids and found that foraminal disc
herniation (P=0.034), foraminal nerve root compromise (P=0.013), and the absence of spinal
canal stenosis (P=0.013) were statistically significant predictors of a positive response to
transforaminal epidural steroid injection and portended a better response to treatment. The
results of our study corroborate these findings. There are some inherent limitations with MRI.
Image quality may be compromised by section thickness, decreased signal-to-noise ratio due to
coil selection and technical parameters, partial volume averaging, and cerebrospinal fluid
pulsation artifact; however, in a comparison of MR multi-echo data image combination sequence
and CT myelography, Dorenbeck, et al. [25] found no statistical differences between these
imaging modalities in the assessment of neuroforaminal or spinal canal narrowing.

Conclusions
Nerve root injections are an important treatment option in the management of patients with
cervical radiculopathy. Although our study population represents only a small subset of patients,
our results suggest that those patients with very small neuroforamina secondary to stenosis
respond well to injection, while those patients with moderate to mild stenosis are less
predictable in their response to injection. While larger prospective studies are needed to verify
these results, measurement of neuroforaminal areas on MRI may represent a useful preprocedural technique to predict which patients with symptoms of cervical radiculopathy
secondary to foraminal stenosis are likely to respond to selective nerve root injections.
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